Ohio Administrative Code|Rule 4731-16-17 | Requirements for one-bite program.

                                                
(A) "One-bite program" is a
		  confidential program for treatment of impaired practitioners of the medical
		  board established pursuant to section 4731.251 of the Revised
		  Code.
(B) "Monitoring organization"
		  is an entity which conducts the one-bite program and performs monitoring
		  services for impaired practitioners under a contract with the medical
		  board.
(C) "One-bite treatment
		  provider" is an entity approved by the board to provide evaluation and
		  treatment to impaired practitioners participating in the one-bite
		  program.
(D) "Continuing care
		  provider" is an entity approved by the board to provide continuing care
		  to impaired practitioners participating in the one-bite program pursuant to
		  rule 4731-16-21 of the Administrative Code.
(E) Licensees of the board who may be impaired in the
		  ability to practice in accordance with acceptable and prevailing standards of
		  care and who want to participate in the one-bite program shall complete the
		  following requirements:
(1) The licensee shall
			 register with the monitoring organization under contract with the board and
			 obtain a list of the one-bite program treatment providers approved by the
			 board.
(2) If the licensee
			 reports directly to an approved treatment provider, the licensee shall register
			 with the monitoring organization upon referral from the approved treatment
			 provider.
(3) The treatment
			 provider shall conduct an evaluation in accordance with rule 4731-16-05 of the
			 Administrative Code. 
(4) The treatment
			 provider shall provide the information regarding the diagnosis and eligibility
			 determination to the monitoring organization for confirmation of
			 eligibility.
(5) If the licensee is
			 determined to be impaired and not to be eligible for the one-bite program, the
			 licensee, the monitoring organization and the treatment provider shall report
			 this information to the board.
(F) Once a licensee is determined to be impaired and
		  eligible for the one-bite program, the licensee shall, within three days,
		  report to an approved treatment provider for treatment. The treatment provider
		  shall develop an individualized treatment plan that may include a combination
		  of inpatient, residential, partial hospitalization and/or intensive outpatient
		  treatment.
(1) The licensee shall be
			 required to immediately suspend practice for a minimum of thirty days. The
			 licensee shall suspend practice until the licensee is determined to be able to
			 practice according to acceptable and prevailing standards by the treatment
			 provider and the medical director of the monitoring organization.
(2) The treatment
			 provider shall notify the board and monitoring organization of any licensee who
			 returns to work prior to obtaining the release from the treatment provider and
			 the monitoring organization medical director.
(3) The treatment
			 provider shall notify the board and monitoring organization of any licensee who
			 does not successfully complete the prescribed treatment.
(G) Within one week after successful completion of
		  treatment, the monitoring organization shall ensure that the licensee has
		  entered into an agreement with a board approved continuing care
		  provider.
(1) The monitoring
			 organization shall confirm that the licensee completes continuing care sessions
			 at least one time per week for at least six months following the release from
			 treatment.
(2) The licensee must
			 continue the weekly continuing care meetings until released by the continuing
			 care provider and the medical director of the monitoring
			 organization.
(H) In order to continue participation in the one-bite
		  program, after successful completion of treatment, the licensee shall enter
		  into an agreement with the monitoring organization for monitoring for at least
		  five years. An individual who chooses not to continue in the one-bite program
		  will be subject to the procedures in rule 4731-16-02 of the Administrative
		  Code.
(1) The licensee shall be
			 required to provide random, observed toxicology screenings of biological
			 materials, including but not limited to, blood, urine, hair, saliva, breath, or
			 fingernail samples for drugs and alcohol as directed by the monitoring
			 organization with a minimum of two random, observed toxicology screenings per
			 month. 
(2) The licensee shall
			 attend drug and alcohol support group meetings (e.g. alcoholics anonymous or
			 narcotics anonymous) as directed by the monitoring organization with a minimum
			 of attendance at ten meetings per month.
(3) The licensee shall be
			 released from monitoring by the medical director of the monitoring organization
			 upon successful completion of monitoring.
(I) Any relapse as defined in paragraph (B) of rule
		  4731-16-01 of the Administrative Code /shall be reported to the board by the
		  medical director of the monitoring organization and the licensee.
(J) The board shall develop guidelines in collaboration
		  with the monitoring organization for the reporting of non-compliance with
		  conditions of the one-bite program. Non-compliance shall be reported to the
		  board by the licensee and the medical director of the monitoring
		  organization.